Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappaB activation, IkappaBalpha phosphorylation, and degradation (Q41075262)

26 September 2017

Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappaB activation, IkappaBalpha phosphorylation, and degradation (English)

1 reference

26 September 2017

0 references

1 reference

Chaturvedi MM

1

1 reference

26 September 2017

Kumar A

2

1 reference

26 September 2017

Darnay BG

3

1 reference

26 September 2017

Chainy GB

4

1 reference

26 September 2017

Agarwal S

5

1 reference

26 September 2017

Aggarwal BB

6

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

Journal of Biological Chemistry

26 September 2017

1 reference

26 September 2017

272

1 reference

26 September 2017

48

1 reference

26 September 2017

30129-30134

1 reference

26 September 2017

Aporphinoid alkaloids

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

Chelerythrine is a potent and specific inhibitor of protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

The effect of sanguinarine on human peripheral blood neutrophil viability and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

Sanguinarine: A positive inotropic alkaloid which inhibits cardiac Na+,K+-ATPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

Structural specificity of the NaK-ATPase inhibition by sanguinarine, an isoquinoline benzophenanthridine alkaloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

Sanguinarine, inhibitor of NaK dependent ATP'ase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

Timing of ethylene and polygalacturonase synthesis in relation to the control of tomato fruit ripening

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

The NF-kappa B and I kappa B proteins: new discoveries and insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

Sanguinarine, a new antiplaque agent: retention and plaque specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

Phototoxic and photochemical properties of sanguinarine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

Inhibition of NF-kappa B by sodium salicylate and aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

Studies into the effect of the tyrosine kinase inhibitor herbimycin A on NF-kappa B activation in T lymphocytes. Evidence for covalent modification of the p50 subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

Membrane Adenosinetriphosphatase: A Digitalis Receptor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

Binding of sanguinarine to deoxyribonucleic acids of differing base composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

The RxxRxRxxC motif conserved in all Rel/kappa B proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

Function and activation of NF-kappa B in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.48.30129

21 January 2018

Identifiers

DOI

10.1074/JBC.272.48.30129

1 reference

26 September 2017

1 reference